GlobalData on MSN
FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy
The approval relies on positive data from the POTOMAC Phase III trial.
The US Food and Drug Administration (FDA) has proposed guidance to reduce the need for animal testing in the development of ...
The Healthy on MSN
FDA: More Seasoning Recalled at Highest Risk Level in 4 States
At least seven products appear to have have been added to what's become a rolling list of items flagged for infection ...
June 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed allowing makers of cell and gene therapies ...
June 2 (Reuters) - Cingulate said on Tuesday that the U.S. Food and Drug Administration declined to approve its drug to treat ...
Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the ...
Here’s where to find a list of impacted products.
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to ...
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from ...
A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.
June 2 () - Shares of Fulcrum Therapeutics plunged 50% in premarket trading on Tuesday after the company said it would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results